Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,110 | -35,888 | -26,629 | -20,755 | -14,911 |
| Depreciation Amortization | 12 | 23 | 17 | 9 | 3 |
| Accounts payable and accrued liabilities | -1,070 | 501 | 854 | 1,295 | 1,804 |
| Other Working Capital | -2,539 | 83 | -153 | 703 | 1,577 |
| Other Operating Activity | 4,539 | 13,367 | 10,725 | 9,402 | 7,736 |
| Operating Cash Flow | $-9,168 | $-21,914 | $-15,186 | $-9,346 | $-3,791 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36 | -55 | -47 | -44 | -2 |
| Investing Cash Flow | $-36 | $-55 | $-47 | $-44 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 17,300 | 17,300 | 10,300 | 6,300 |
| Debt Repayment | -14,970 | -600 | -366 | -192 | -138 |
| Common Stock Issued | 56,776 | 16,406 | 373 | 143 | 143 |
| Other Financing Activity | -1,312 | -100 | 0 | 0 | 0 |
| Financing Cash Flow | $40,494 | $33,006 | $17,307 | $10,251 | $6,305 |
| Beginning Cash Position | 17,256 | 6,219 | 6,219 | 6,219 | 6,219 |
| End Cash Position | 48,546 | 17,256 | 8,293 | 7,080 | 8,731 |
| Net Cash Flow | $31,290 | $11,037 | $2,074 | $861 | $2,512 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,168 | -21,914 | -15,186 | -9,346 | -3,791 |
| Capital Expenditure | -36 | -55 | -47 | -44 | -2 |
| Free Cash Flow | -9,204 | -21,969 | -15,233 | -9,390 | -3,793 |